Cochrane Abstracts
The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"The Effects of Idarubicin Versus Other Anthracyclines for Induction Therapy of Patients With Newly Diagnosed Leukaemia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/Intraperitoneal_chemotherapy_for_the_initial_management_of_primary_epithelial_ovarian_cancer_Edited__no_change_to_conclusions_. Accessed 01 October 2023.
The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/Intraperitoneal_chemotherapy_for_the_initial_management_of_primary_epithelial_ovarian_cancer_Edited__no_change_to_conclusions_. Accessed October 1, 2023.
The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/Intraperitoneal_chemotherapy_for_the_initial_management_of_primary_epithelial_ovarian_cancer_Edited__no_change_to_conclusions_
The Effects of Idarubicin Versus Other Anthracyclines for Induction Therapy of Patients With Newly Diagnosed Leukaemia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 October 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/Intraperitoneal_chemotherapy_for_the_initial_management_of_primary_epithelial_ovarian_cancer_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia: Cochrane systematic review
ID - 432908
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432908/all/Intraperitoneal_chemotherapy_for_the_initial_management_of_primary_epithelial_ovarian_cancer_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
